NRAS and acute myeloid leukemia: Briefly, tNM AML cells conditionally express the NRAS(V12) oncogene from a tetracycline-response element (TRE) promoter, and NRAS(V12) transcription can be suppressed by administering the tetracycline analog doxycycline (Dox).